Abstract
Synthesis of a new various drug delivery systems (DDS) could develop to provide the modifications and improve the therapeutic efficiency and safety of drugs. These may cause a reduction in size and number of doses, side effects, and biological inactivation and elimination. Also, the benefits may include lower toxicity and higher specificity of action This study includes the preparation of new polymers for chitosan by the interaction of chitosan with different drugs carrying carboxylic groups (cephalexin, ciprofloxacin, amoxicillin, mefenamic acid) after conversion into acid chloride derivatives and diagnosis of the resulting compounds using the FT-IR and HNMR spectrum. How to cite this article: Hassen, T.F., Mohammed, F.H. (2019). Synthesis and Modification of Some New Prodrug Polymers Based on Chitosan and Study of Some Applications. International Journal of Drug Delivery Technology, 9(4): 580-586. Source of support: Nil. Conflict of interest: None.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
